Filing Details
- Accession Number:
- 0001104659-22-035347
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-18 08:31:48
- Reporting Period:
- 2022-03-17
- Accepted Time:
- 2022-03-18 08:31:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1875558 | Nuvectis Pharma Inc. | NVCT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Chairman & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.00001 | Acquisiton | 2022-03-17 | 7,000 | $7.63 | 2,821,459 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 96,759 shares of restricted stock.
Billionaire Hedge Funds
